Salmeterol effects on parasternal intercostal activity at maximum sniff Source: Eur Respir J 2005; 26: Suppl. 49, 571s Year: 2005
Inhaled salmeterol/fluticasone increases diaphragm contractility in awake canines Source: Eur Respir J 2007; 30: Suppl. 51, 730s Year: 2007
Salbutamol effects on parasternal intercostal activity at maximum sniff in humans Source: Eur Respir J 2003; 22: Suppl. 45, 469s Year: 2003
Duration of the effect of inhaled salmeterol on walking distance Source: Eur Respir J 2002; 20: Suppl. 38, 114s Year: 2002
Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD Source: Eur Respir J 2003; 21: 86-94 Year: 2003
Aminophylline increases parasternal intercostal muscle activity during hypoxia Source: Eur Respir J 2006; 28: Suppl. 50, 622s Year: 2006
Budesonide prevents cytokine-induced decrease of the relaxant response to formoterol but not to salmeterol in mouse trachea Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009
Inhaled vilanterol trifenatate/fluticasone furoate increases maximum diaphragm contraction in severe COPD Source: International Congress 2014 – Clinical physiology and respiratory muscles Year: 2014
Effects of extra fine formoterol or coarse particle salmeterol on impulse oscillometry (IOS) in corticosteroid treated persistent asthmatics Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015
Differentiation of bronchodilator effects of indacaterol and formoterol by FEV1 and inspiratory capacity (IC) in patients with COPD Source: Annual Congress 2007 - New drugs for COPD Year: 2007
Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Attenuation of exercise-induced bronchoconstriction with montelukast or salmeterol added to inhaled fluticasone in children Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Effect of inhaled fenoterol on the response to inspiratory threshold loading Source: Eur Respir J 2001; 18: Suppl. 33, 86s Year: 2001
Inhaled vilanterol trifenatate/fluticasone furoate (VFF) improves respiratory muscle function and walking performance in severe COPD without change in pulmonary function Source: International Congress 2017 – Management of COPD Year: 2017
Respiratory muscle strength after inhaled short acting beta-agonist administration in stable COPD patients Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests Year: 2012
Severity of nocturnal asthma, as measured by pulmonary function tests and electromyogram of the parasternal intercostals Source: Annual Congress 2010 - Innovations in the assessment of airway diseases Year: 2010
Use of the diaphragm electromyogram to assess bronchodilator response in asthma and COPD Source: Annual Congress 2007 - Advances in respiratory muscles Year: 2007
Impulse oscillometry parameters of COPD patients during inspiration and expiration and the effect of tiotropium inhalation therapy Source: Annual Congress 2008 - Beyond spirometry: the skills behind lung function testing Year: 2008
Timecourse of action of two inhaled corticosteroids, fluticasone propionate and budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 308s Year: 2002
Impulse oscillometry in evaluation therapy with combination fluticasone propionate and salmeterol in asthma patients Source: Annual Congress 2007 - New insight into the pathophysiology of asthma Year: 2007